AAAAAA

   
Results: 1-13 |
Results: 13
High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience
Authors: Cao, TM Horning, SF Negrin, RS Hu, WW Johnston, LF Taylor, TL Shizuru, JA Hoppe, RT Brown, BW Blume, KG Stockerl-Goldstein, K
Citation: Tm. Cao et al., High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience, BIOL BLOOD, 7(5), 2001, pp. 294-301
Engineering hematopoietic grafts: Purified allogeneic hematopoietic stem cells plus expanded CD8(+) NK-T cells in the treatment of lymphoma
Authors: Verneris, MR Ito, M Baker, E Arshi, A Negrin, RS Shizuru, JA
Citation: Mr. Verneris et al., Engineering hematopoietic grafts: Purified allogeneic hematopoietic stem cells plus expanded CD8(+) NK-T cells in the treatment of lymphoma, BIOL BLOOD, 7(10), 2001, pp. 532-542
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease
Authors: Stuart, MJ Chao, NS Horning, SJ Wong, RM Negrin, RS Johnston, LJ Shizuru, JA Long, GD Blume, KG Stockerl-Goldstein, KE Goldstein, S
Citation: Mj. Stuart et al., Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease, BIOL BLOOD, 7(10), 2001, pp. 552-560
Toward regenerative medicine
Authors: Lagasse, E Shizuru, JA Uchida, N Tsukamoto, A Weissman, IL
Citation: E. Lagasse et al., Toward regenerative medicine, IMMUNITY, 14(4), 2001, pp. 425-436
Immunity to infections following hematopoietic cell transplantation
Authors: Brown, JM Weissman, IL Shizuru, JA
Citation: Jm. Brown et al., Immunity to infections following hematopoietic cell transplantation, CURR OP IM, 13(4), 2001, pp. 451-457
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
Authors: McSweeney, PA Niederwieser, D Shizuru, JA Sandmaier, BM Molina, AJ Maloney, DG Chauncey, TR Gooley, TA Hegenbart, U Nash, RA Radich, J Wagner, JL Minor, S Appelbaum, FR Bensinger, WI Bryant, E Flowers, MED Georges, GE Grumet, FC Kiem, HP Torok-Storb, B Yu, G Blume, KG Storb, RF
Citation: Pa. Mcsweeney et al., Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects, BLOOD, 97(11), 2001, pp. 3390-3400
Expansion of cytolytic CD8(+) natural killer T cells with limited capacityfor graft-versus-host disease induction due to interferon gamma production
Authors: Baker, J Verneris, MR Ito, M Shizuru, JA Negrin, RS
Citation: J. Baker et al., Expansion of cytolytic CD8(+) natural killer T cells with limited capacityfor graft-versus-host disease induction due to interferon gamma production, BLOOD, 97(10), 2001, pp. 2923-2931
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation
Authors: Cao, TM Negrin, RS Stockerl-Goldstein, KE Johnston, LJ Shizuru, JA Taylor, TL Rizk, NW Wong, RM Blume, KG Hu, WW
Citation: Tm. Cao et al., Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation, BIOL BLOOD, 6(4), 2000, pp. 387-394
Transplantation of highly purified CD34(+)Thy-I+ hematopoietic stem cells in patients with metastatic breast cancer
Authors: Negrin, RS Atkinson, K Leemhuis, T Hanania, E Juttner, C Tierney, K Hu, WW Johnston, LJ Shizuru, JA Stockerl-Goldstein, KE Blume, KG Weissman, IL Bower, S Baynes, R Dansey, R Karanes, C Peters, W Klein, J
Citation: Rs. Negrin et al., Transplantation of highly purified CD34(+)Thy-I+ hematopoietic stem cells in patients with metastatic breast cancer, BIOL BLOOD, 6(3), 2000, pp. 262-271
Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: No improvement in outcomes compared with single-course high-dose therapy
Authors: Hu, WW Negrin, RS Stockerl-Goldstein, K Johnston, LJ Shizuru, JA Wong, RM Chao, NJ Long, GD Feiner, RH Blume, KG
Citation: Ww. Hu et al., Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: No improvement in outcomes compared with single-course high-dose therapy, BIOL BLOOD, 6(1), 2000, pp. 58-69
Effect of oral glutamine supplementation during bone marrow transplantation
Authors: Dickson, TMC Wong, RM Negrin, RS Shizuru, JA Johnston, LJ Hu, WW Blume, KG Stockerl-Goldstein, KE
Citation: Tmc. Dickson et al., Effect of oral glutamine supplementation during bone marrow transplantation, J PARENT EN, 24(2), 2000, pp. 61-66
Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection
Authors: Shizuru, JA Weissman, IL Kernoff, R Masek, M Scheffold, YC
Citation: Ja. Shizuru et al., Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection, P NAS US, 97(17), 2000, pp. 9555-9560
Immune reconstitution
Authors: Weissman, IL Shizuru, JA
Citation: Il. Weissman et Ja. Shizuru, Immune reconstitution, N ENG J MED, 341(16), 1999, pp. 1227-1229
Risultati: 1-13 |